The briefing
University of Pittsburgh researchers report that three transplant recipients were able to discontinue immunosuppressants after receiving donor-derived immune cells. The approach is experimental and did not succeed in all cases, underscoring the need for further study.
Original headline
New Treatment Lets 3 Transplant Patients Halt Anti-Rejection Drugs